After a 30 year effort, 2016 data show a 17% reduction in hospital-acquired conditions (HACs). This is amazing progress! These data show a 2.1 million case decline in avoidable HAC in US patients and 87,000 lives saved.
The money saved in the US healthcare system was estimated at $19.8 billion in 2014. If hospitals can do it, medtech can help – a medical device designed and proven to reduce HAC brings significant economic value that may warrant premium pricing. Read the entire article…
Other articles by the Medi-Vantage team:
Read an article about Marlou Janssen, CEO of Biotronik and her impressive career and outstanding results at Biotronik. Marlou Janssen, US CEO of Biotronik
Why is drug delivery so critical to the medtech industry? Read the entire article…
How can we help you?
Let us know using the contact form below. Out most recent three client engagements were for:
- Pricing Strategy (non-conjoint, but we do conjoint also)
- Due Diligence for a possible M&A
- Commercialization strategy for a European client entering the US in 2018
- Identifying features in a device to improve its status as a Physician Preference Item